In India, 2L+ people have MS, but lack standard care. Experts at a Bengaluru event urged for better data, insurance, and ...
Zacks Investment Research on MSN
Novartis' ianalumab wins breakthrough therapy tag for Sjogren's disease
Novartis NVS announced that the FDA granted Breakthrough Therapy designation to its pipeline candidate, ianalumab for the ...
VANCOUVER, BC / ACCESS Newswire / January 19, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
VANCOUVER, BC / ACCESS Newswire / January 19, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery s ...
Bengaluru Chapter, in collaboration with the Rotary Action Group Against Multiple Sclerosis (RAGAMS), hosted an awareness and ...
After JP Morgan, the company is focusing on getting ready to submit a biologics license application to the FDA for miv-cel in ...
In addition to PH, columnist Jolie Lizana faces a possible scleroderma diagnosis, as coexisting conditions continue to ...
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously referred to as NAFLD, represents the most prevalent liver disorder globally, ...
The Commonwealth Transportation Board at its Jan. 6 meeting in Richmond awarded a $218.9 million contract to Triton ...
The prevalence of autoimmune diseases is increasing, especially in women, and the ongoing winter season, along with high ...
Opportunities lie in strategic investment formulation, identifying cost-effective locations for conducting trials, understanding global trial trends, and analyzing trial success rates. Insights into ...
The prevalence of autoimmune diseases is increasing, especially in women, and the ongoing winter season, along with high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback